Insight / Operator brief

Kidney Payment Reform Still Depends on Referral and Intake Operations

The Kidney Care Choices Model has shown quality gains and spending pressure at the same time. The operating lesson is direct: payment design cannot deliver coordinated kidney care unless referral, education, intake, modality choice, and handoffs work reliably.

Return to insights

Kidney care entities, nephrology groups, dialysis networks, care-management platforms, payers, and healthcare operators / 2026-07-19

By Healthcare growth and AI operations executive

Founder question

Which referral, intake, education, or care-coordination failure prevents a kidney payment model from becoming a better patient pathway?

Public factsOperator interpretationBuyer implicationsFounder action

Model findings and changes are attributed to CMS. Operating recommendations are independent analysis and do not claim clinical or financial outcomes for a specific organization.

Executive thesis

Source-backed operator read.

Kidney value-based care is an operating pathway before it is a payment model. CMS reports meaningful quality gains in home dialysis, optimal starts, and transplant-related measures alongside net Medicare losses that prompted financial-method changes and an extension through 2027. The implication is not that coordination failed. It is that the pathway and economics must be managed together, with earlier patient identification, reliable referral, faster intake, supported modality choice, and visible utilization drivers.

Public facts

  1. CMS says the Kidney Care Choices Model runs through 2027 and is intended to delay dialysis, support transplantation, reduce cost, and improve coordinated care for late-stage CKD and ESRD.

  2. CMS reports that the model's second performance year improved home-dialysis use, optimal starts, and certain transplant measures while producing a statistically significant net Medicare loss for 2023.

  3. CMS implemented 2026 financial and participation changes intended to improve sustainability, including benchmark discounts and changes to capitation and model options.

Operator read

  1. The model's mixed result shows why quality and economics must share one operating dashboard. A better modality outcome does not automatically produce net savings in the same period.

  2. Patient identification and referral timing are core levers. Late engagement reduces the opportunity for education, access placement, home readiness, transplant evaluation, and planned starts.

  3. The intake system must expose clinical, payer, documentation, social, and capacity barriers in one work queue rather than distributing them across teams.

  4. The expansion thesis should follow cohorts where the pathway and economics both repeat, not broad patient counts alone.

Operating model

Turn the thesis into a decision system.

The framework defines the work; the metrics define whether the work is creating value.

Operating framework

  1. 01

    Identify eligible patients early enough for education, nephrology engagement, and planned modality choice.

  2. 02

    Map referral source, clinical readiness, payer status, documentation, scheduling, acceptance, and first treatment as one conversion path.

  3. 03

    Give the patient a supported choice across delayed progression, home modalities, in-center care, transplant, and conservative care where appropriate.

  4. 04

    Create shared work queues and escalation across nephrology, dialysis, transplant, primary care, and care management.

  5. 05

    Measure quality and net spending with the operating drivers visible underneath them.

Metrics that matter

  1. 01

    Time from identification to nephrology engagement

  2. 02

    Planned and optimal dialysis starts

  3. 03

    Home-modality education and activation

  4. 04

    Referral acceptance and intake cycle time

  5. 05

    Total cost and avoidable utilization by patient cohort

Buyer implications

  1. Kidney operators should connect referral operations to quality and total-cost outcomes.

  2. Payers should diligence the patient-identification, intake, education, modality, and exception workflow underneath reported results.

  3. Technology partners should prove earlier action and completed handoffs, not merely risk identification.

Founder actions

  1. Build the patient journey from first risk signal through longitudinal kidney care.

  2. Instrument referral age, missing requirements, capacity, payer friction, and next owner.

  3. Pair every quality metric with its utilization and cost drivers.

  4. Use one high-friction corridor to prove the operating model before network expansion.

Red flags

  1. Patients are identified after the window for education and planned choice has narrowed.

  2. Referral dashboards do not expose missing documents, payer friction, or accountable owners.

  3. Quality gains are reported without the operating and spending drivers needed to sustain them.

CEO and CFO questions

  1. Where does the patient first become visible and who acts?

  2. Which intake barriers delay an optimal start or modality choice?

  3. How are nephrology, dialysis, transplant, and primary care handoffs governed?

  4. Which quality improvement also changes net spending?

Provider network growth strategyPayer strategy and value-based careDialysis network growthProvider network growth strategyPayer strategy and value-based careDialysis network growthClaims forensics

Connect patient identification, referral, intake, modality, capacity, quality, and economics into one operating system.

Map the kidney care pathway

Start a serious conversation

Use the market signal before it becomes consensus.

Discuss an operating mandate